Methods of Making Bempedoic Acid and Compositions of the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application PCT/US2020/038622, filed Jun 19, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,407,705 | Methods of Making Bempedoic Acid and Compositions of the Same In force · High confidence UsedRemaining | Esperion Therapeutics, Inc. | In force | High confidence | ||
| US 11,613,511 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | Esperion Therapeutics, Inc. | In force | Medium confidence | ||
| US 11,760,714 | Methods of Making Bempedoic Acid and Compositions of the Same In force · High confidence | Esperion Therapeutics, Inc. | In force | High confidence | ||
| US 11,926,584 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | Esperion Therapeutics, Inc. | In force | Medium confidence | ||
| US 11,987,548 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | Esperion Therapeutics, Inc. | In force | Medium confidence | ||
| US 12,398,087 | Methods of Making Bempedoic Acid and Compositions of the Same In force · Medium confidence | Esperion Therapeutics, Inc. | In force | Medium confidence | ||
| US 12,404,227 | Methods of Making Bempedoic Acid and Compositions of the Same In force · High confidence | Esperion Therapeutics, Inc. | In force | High confidence | ||
| Application 17/150,321 | Methods of Making Bempedoic Acid and Compositions of the Same Abandoned Abandoned Mar 31, 2022 | Esperion Therapeutics, Inc. | Abandoned | Abandoned Mar 31, 2022 | ||
| Application 18/632,996 | Methods of Making Bempedoic Acid and Compositions of the Same Abandoned Abandoned Jul 20, 2026 | Esperion Therapeutics, Inc. | Abandoned | Abandoned Jul 20, 2026 | ||
| Application 19/280,575 | Methods of Making Bempedoic Acid and Compositions of the Same Pending Not granted | Esperion Therapeutics, Inc. | Pending | Not granted | ||
| 1 more record in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
7 of these are in force and held by Esperion Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.